1
1
Bhubaneswar: Anthem Biosciences Limited (the “Company”) proposes to open an initial public offering (“Offer”) of its equity shares of face value of ₹2 each (“Equity Shares”) on Monday, July 14, 2025. The Anchor Investor Bidding Date is one Working Day prior to Bid/Offer Opening Date, being Friday, July 11, 2025. The Bid/ Offer Closing Date is Wednesday, July 16, 2025.
The Price Band of the Offer has been fixed from ₹ 540 per Equity Share to ₹ 570 per Equity Share. Bids can be made for a minimum of 26 Equity Shares and multiples of 26 Equity Shares thereafter.
The Initial Public Offering comprises an Offer for Sale of Equity Shares aggregating up ₹33,950 million by the Selling Shareholders comprising of Equity Shares aggregating up to ₹3,500 million by Ganesh Sambasivam; Equity Shares aggregating up to ₹3,500 million by K Ravindra Chandrappa; Equity Shares aggregating up to ₹ 13,250 million by Viridity Tone LLP; Equity Shares aggregating up to ₹ 3,200 million each by Portsmouth Technologies LLC, Malay J Barua, Rupesh N Kinekar and Satish Sharma; Equity Shares aggregating up to ₹ 800 million by Prakash Kariabettan and Equity Shares aggregating up to ₹ 100 million by K Ramakrishnan.
The Offer includes a reservation of Equity Shares of face value of ₹2 each, aggregating up to ₹ 82.50 million for subscription by Eligible Employees (the “Employee Reservation Portion”). The Offer less the Employee Reservation Portion is hereinafter referred to as the “Net Offer”. A discount of ₹50 per Equity Share is being offered to Eligible Employees bidding in the Employee Reservation Portion (“Employee Discount”).